Edap Tms (NASDAQ:EDAP) Announces Quarterly Earnings Results

Edap Tms (NASDAQ:EDAP) posted its quarterly earnings results on Thursday. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06, Zacks reports. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%.

Edap Tms Price Performance

EDAP traded up $0.25 during midday trading on Thursday, hitting $2.30. 376,031 shares of the company traded hands, compared to its average volume of 85,668. The business has a 50 day simple moving average of $2.42 and a two-hundred day simple moving average of $2.52. Edap Tms has a 52-week low of $1.96 and a 52-week high of $8.50. The company has a market capitalization of $85.15 million, a price-to-earnings ratio of -3.53 and a beta of 0.37. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Edap Tms in a research report on Thursday, March 20th. They issued a “hold” rating on the stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.